IOIsaac Orikushaba

Isaac Orikushaba

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Isaac Orikushaba has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Molecular characterization of extended-spectrum beta-lactamase-producing bacteria isolated from pregnant women’s urine at Itojo Hospital, South Western Uganda

    by Muzafaru Twinomujuni, Benson Musinguzi, Moses Asiimwe, Stephen Samuel Mpiima, Henry Zamarano, Isaac Orikushaba, Deus Muhanguzi, Crinad Twinamatsiko, Sarapia Paul Mallya, Jamiru Samiri, et al.

    Background. Extended-spectrum β -lactamase (ESBL)-producing bacteria pose a global challenge because of resistance developing against a wide range of antimicrobial agents, complicating available treatment options. Thus, identifying the prevalent bacterial species producing ESBL enzymes and understanding how they are susceptible to antibiotics is necessary to inform effective treatment guidelines. Objective. We sought to characterize ESBL-producing bacteria isolated from pregnant women’s urine at Itojo Hospital, Ntungamo district, Southwestern Uganda. Methods. We conducted a cross-sectional study where we collected and analysed 340 urine samples from 340 pregnant women. We did antimicrobial susceptibility testing using the Kirby–Bauer disc diffusion method. Isolates were screened for ESBL production and confirmed using the combination disc test. Genotypic characterization was confirmed using multiplex PCR to detect bla TEM, bla CTX-M and bla SHV genes. Results. The prevalence of ESBL-producing bacteria was 29.7% (101/340). Escherichia coli 36/101 (35.6%) and Klebsiella species 33/101 (32.7%) were predominant ESBL producers. Genotypic analysis revealed bla TEM 50/101 (49.5%) and bla CTX-M 31/101 (30.7%) as the most prevalent genes, while bla SHV was less common, 8/101 (7.9%) Conclusion. The high prevalence of ESBL-producing bacteria and their resistance to commonly used antibiotics highlighted the need for targeted antibiotic therapy, antimicrobial stewardship and regular molecular surveillance.


  • Open Access

    Prevalence and Molecular Characterization of Extended Spectrum Beta Lactamase Bacteria Causing Urinary Tract Infections in Pregnant Mothers at Itojo Hospital, South Western Uganda

    by Muzafaru Twinomujuni, Musinguzi Benson, Moses Asiimwe, Stephen Samuel Mpiima, Henry Zamarano, Isaac Orikushaba, Deus Muhanguzi, Crinad Twinamatsiko, Sarapia Paul Mallya, Jamiru Samiri, et al.

    Background Extended-spectrum β-lactamase (ESBL) producing bacteria pose a global challenge because of resistance developing against a wide range of antimicrobial agents that complicate available treatment options. Thus, identifying the prevalent bacterial species producing ESBL enzymes and understanding how they are susceptible to antibiotics is necessary internationally to inform the effective treatment guidelines. Objective To determine the prevalence and molecular characterization of ESBL bacteria causing Urinary Tract Infections (UTIs) in women who are pregnant at the Itojo Hospital, Ntungamo District. Methods We conducted cross-sectional study where we collected and analyzed 340 urine samples. We did antimicrobial susceptibility testing using the Kirby Bauer disk diffusion method. Isolates were screened for ESBL production and confirmed using the combination disk test (CDT). Genotypic characterization was confirmed using multiplex PCR to detect blaTEM, blaCTX-M and blaSHV genes. Results The prevalence of ESBL – producing bacteria was 29.7% (101/340). Escherichia coli (35.6%) and Klebsiella species (32.7%) were predominant ESBL producers. Genotypic analysis revealed blaTEM (49.5%) and blaCTX-M (30.7%) as the most prevalent genes, while blaSHV was less common (7.9%) Conclusion The high prevalence of ESBL–producing bacteria and their resistance to commonly used antibiotics highlight the need for targeted antibiotic therapy, antimicrobial stewardship, and regular molecular surveillance.

  • Open Access

    Prevalence and Molecular Characterization of Extended Spectrum Beta Lactamase Bacteria Causing Urinary Tract Infections in Pregnant Mothers at Itojo Hospital, South Western Uganda

    by Muzafaru Twinomujuni, Musinguzi Benson, Moses Asiimwe, Stephen Samuel Mpiima, Henry Zamarano, Isaac Orikushaba, Deus Muhanguzi, Crinad Twinamatsiko, Sarapia Paul Mallya, Jamiru Samiri, et al.

    Background Extended-spectrum β-lactamase (ESBL) producing bacteria pose a global challenge because of resistance developing against a wide range of antimicrobial agents that complicate available treatment options. Thus, identifying the prevalent bacterial species producing ESBL enzymes and understanding how they are susceptible to antibiotics is necessary internationally to inform the effective treatment guidelines. Objective To determine the prevalence and molecular characterization of ESBL bacteria causing Urinary Tract Infections (UTIs) in women who are pregnant at the Itojo Hospital, Ntungamo District. Methods We conducted cross-sectional study where we collected and analyzed 340 urine samples. We did antimicrobial susceptibility testing using the Kirby Bauer disk diffusion method. Isolates were screened for ESBL production and confirmed using the combination disk test (CDT). Genotypic characterization was confirmed using multiplex PCR to detect blaTEM, blaCTX-M and blaSHV genes. Results The prevalence of ESBL – producing bacteria was 29.7% (101/340). Escherichia coli (35.6%) and Klebsiella species (32.7%) were predominant ESBL producers. Genotypic analysis revealed blaTEM (49.5%) and blaCTX-M (30.7%) as the most prevalent genes, while blaSHV was less common (7.9%) Conclusion The high prevalence of ESBL–producing bacteria and their resistance to commonly used antibiotics highlight the need for targeted antibiotic therapy, antimicrobial stewardship, and regular molecular surveillance.

  • Open Access

    Prevalence and Molecular Characterization of Extended Spectrum Beta Lactamase Bacteria Causing Urinary Tract Infections in Pregnant Mothers at Itojo Hospital, South Western Uganda

    by Muzafaru Twinomujuni, Musinguzi Benson, Moses Asiimwe, Stephen Samuel Mpiima, Henry Zamarano, Isaac Orikushaba, Deus Muhanguzi, Crinad Twinamatsiko, Sarapia Paul Mallya, Jamiru Samiri, et al.

    Background Extended-spectrum β-lactamase (ESBL) producing bacteria pose a global challenge because of resistance developing against a wide range of antimicrobial agents that complicate available treatment options. Thus, identifying the prevalent bacterial species producing ESBL enzymes and understanding how they are susceptible to antibiotics is necessary internationally to inform the effective treatment guidelines. Objective To determine the prevalence and molecular characterization of ESBL bacteria causing Urinary Tract Infections (UTIs) in women who are pregnant at the Itojo Hospital, Ntungamo District. Methods We conducted cross-sectional study where we collected and analyzed 340 urine samples. We did antimicrobial susceptibility testing using the Kirby Bauer disk diffusion method. Isolates were screened for ESBL production and confirmed using the combination disk test (CDT). Genotypic characterization was confirmed using multiplex PCR to detect blaTEM, blaCTX-M and blaSHV genes. Results The prevalence of ESBL – producing bacteria was 29.7% (101/340). Escherichia coli (35.6%) and Klebsiella species (32.7%) were predominant ESBL producers. Genotypic analysis revealed blaTEM (49.5%) and blaCTX-M (30.7%) as the most prevalent genes, while blaSHV was less common (7.9%) Conclusion The high prevalence of ESBL–producing bacteria and their resistance to commonly used antibiotics highlight the need for targeted antibiotic therapy, antimicrobial stewardship, and regular molecular surveillance.

  • Open Access

    Prevalence and Molecular Characterization of Extended Spectrum Beta Lactamase Bacteria Causing Urinary Tract Infections in Pregnant Mothers at Itojo Hospital, South Western Uganda

    by Muzafaru Twinomujuni, Musinguzi Benson, Moses Asiimwe, Stephen Samuel Mpiima, Henry Zamarano, Isaac Orikushaba, Deus Muhanguzi, Crinad Twinamatsiko, Sarapia Paul Mallya, Jamiru Samiri, et al.

    Background Extended-spectrum β-lactamase (ESBL) producing bacteria pose a global challenge because of resistance developing against a wide range of antimicrobial agents that complicate available treatment options. Thus, identifying the prevalent bacterial species producing ESBL enzymes and understanding how they are susceptible to antibiotics is necessary internationally to inform the effective treatment guidelines. Objective To determine the prevalence and molecular characterization of ESBL bacteria causing Urinary Tract Infections (UTIs) in women who are pregnant at the Itojo Hospital, Ntungamo District. Methods We conducted cross-sectional study where we collected and analyzed 340 urine samples. We did antimicrobial susceptibility testing using the Kirby Bauer disk diffusion method. Isolates were screened for ESBL production and confirmed using the combination disk test (CDT). Genotypic characterization was confirmed using multiplex PCR to detect blaTEM, blaCTX-M and blaSHV genes. Results The prevalence of ESBL – producing bacteria was 29.7% (101/340). Escherichia coli (35.6%) and Klebsiella species (32.7%) were predominant ESBL producers. Genotypic analysis revealed blaTEM (49.5%) and blaCTX-M (30.7%) as the most prevalent genes, while blaSHV was less common (7.9%) Conclusion The high prevalence of ESBL–producing bacteria and their resistance to commonly used antibiotics highlight the need for targeted antibiotic therapy, antimicrobial stewardship, and regular molecular surveillance.

  • Open Access

    Streptococcus pneumoniae carriage and antibiotic use in children in southwestern Uganda

    by Birungi Mutahunga, Nahabwe Haven, Orikushaba I. Magezi, James Mubangizi, Yusufu Kuule, Peter R. Scull, Frank M. Frey

    Background: Acute respiratory infection is a significant health threat in children under the age of 5 years in Uganda and can be caused by Streptococcus pneumoniae. Aim: This study documents caretaker behaviour in seeking treatment for suspected acute respiratory infection in children and estimates the prevalence of S. pneumoniae in healthy and sick children. Setting: The study was carried out in the catchment region of Bwindi Community Hospital, encompassing the sub-counties of Kanyantorogo, Kayonza and Mpungu in rural southwestern Uganda. Methods: This cross-sectional study was conducted from January 2023 to August 2023. Caretakers answered questions about the child’s illness, symptoms, sources of treatment and medicines administered. Nasopharyngeal swabs were collected from children and cultured to identify S. pneumoniae using standard microbiological methods. Analyses were conducted using SPSS and ArcPro GIS. Results: Roughly half of the 422 families sampled reported that the child was ill within the past 2 weeks, the vast majority with symptoms consistent with a possible acute respiratory infection. Most (80%) sought treatment outside the home at a private or public health facility or drug shop. Regardless of treatment source, antibiotics (primarily amoxicillin) were administered 56% of the time. The prevalence of S. pneumoniae was 34% and positively associated with household density, household size and the number of children in the household. Conclusion: This study documents a high carriage rate of S. pneumoniae in the region and documents a high rate of antibiotic use in the region. Contribution: This study provides evidence to support a wider assessment of S. pneumoniae carriage and the potential for antibiotic resistance.